跳至主要内容
临床试验/NCT02165475
NCT02165475已完成不适用

Combination Therapy With Biofeedback, Loperamide and Stool Bulking Agents is Effective for the Treatment of Fecal Incontinence in Women - a Randomized Controlled Trial

University Hospital, Linkoeping1 个研究点 分布在 1 个国家开始时间: 2002年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
试验地点
1
主要终点
symptom diary

研究概览

简要总结

Background: Biofeedback and medical treatments have been extensively used for moderate fecal incontinence. There is limited data comparing and combining these two treatments.

Aim: To evaluate the effect of biofeedback and medical treatments, separately and in combination.

Methods: Sixty-five consecutive female patients, referred to a tertial center for fecal incontinence were included. The patients were randomized to start with either biofeedback (4-6 months) or medical treatment with loperamide and stool-bulking agents (2 months). Both groups continued with a combination treatments, i.e. medical treatment was added to biofeedback and vice versa. A two-week prospective bowel symptom diary and anorectal physiology were evaluated at baseline, after single- and combination treatments.

研究设计

研究类型
Interventional
主要目的
Treatment

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients older than 18 years of age
  • Patients with at least one or more episodes of FI during a period of 2 weeks as recorded by bowel function diary
  • Patients from whom written consent was obtained

排除标准

  • Previous congenital or acquired spinal injury, spinal tumour or spinal surgery
  • Presence of neurological diseases or peripheral vascular disease
  • Uncontrolled diabetes mellitus
  • Congenital anorectal malformations
  • Recent colorectal or gastrointestinal surgery
  • Presence of external full-thickness rectal prolapse
  • Inflammatory bowel disease
  • Chronic diarrhoea
  • Use of tibial nerve or sacral nerve stimulations
  • Ongoing pregnancy
  • Any malignant disease

研究组 & 干预措施

Biofeedback

Experimental

干预措施: Biofeedback (Behavioral)

medical treatment

Experimental

干预措施: Loperamide (Drug)

medical treatment

Experimental

干预措施: Stool bulking agent (stericulia or isphagula husk) (Drug)

combination of the two treatments

Experimental

干预措施: Combination of biofeedback and medical treatment (Other)

结局指标

主要结局

symptom diary

时间窗: Up to eight months

次要结局

未报告次要终点

研究者

发起方
University Hospital, Linkoeping
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jenny Sjödahl

PhD

University Hospital, Linkoeping

研究点 (1)

Loading locations...

相似试验